A detailed history of Stifel Financial Corp transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Stifel Financial Corp holds 294,215 shares of TAK stock, worth $3.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
294,215
Previous 208,443 41.15%
Holding current value
$3.86 Million
Previous $2.97 Million 37.39%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.89 - $15.04 $1.19 Million - $1.29 Million
85,772 Added 41.15%
294,215 $4.09 Million
Q4 2023

Feb 12, 2024

SELL
$13.36 - $15.43 $1.14 Million - $1.32 Million
-85,370 Reduced 29.06%
208,443 $2.97 Million
Q3 2023

Nov 13, 2023

BUY
$15.03 - $16.32 $221,932 - $240,981
14,766 Added 5.29%
293,813 $4.55 Million
Q2 2023

Aug 14, 2023

BUY
$15.57 - $17.11 $60,084 - $66,027
3,859 Added 1.4%
279,047 $4.38 Million
Q1 2023

May 12, 2023

BUY
$15.28 - $16.48 $2.47 Million - $2.67 Million
161,919 Added 142.95%
275,188 $4.54 Million
Q4 2022

Feb 13, 2023

SELL
$12.42 - $15.62 $129,515 - $162,885
-10,428 Reduced 8.43%
113,269 $1.77 Million
Q3 2022

Nov 14, 2022

BUY
$12.8 - $28.65 $194,329 - $434,964
15,182 Added 13.99%
123,697 $1.6 Million
Q2 2022

Aug 15, 2022

BUY
$13.12 - $15.03 $166,348 - $190,565
12,679 Added 13.23%
108,515 $1.52 Million
Q1 2022

May 13, 2022

BUY
$13.54 - $15.35 $120,289 - $136,369
8,884 Added 10.22%
95,836 $1.37 Million
Q4 2021

Feb 14, 2022

BUY
$13.17 - $16.4 $134,492 - $167,476
10,212 Added 13.31%
86,952 $1.19 Million
Q3 2021

Nov 15, 2021

BUY
$16.3 - $17.26 $198,501 - $210,192
12,178 Added 18.86%
76,740 $1.26 Million
Q2 2021

Aug 13, 2021

BUY
$16.55 - $18.64 $6,338 - $7,139
383 Added 0.6%
64,562 $1.09 Million
Q1 2021

May 14, 2021

SELL
$16.71 - $19.9 $1.56 Million - $1.85 Million
-93,125 Reduced 59.2%
64,179 $1.17 Million
Q4 2020

Feb 12, 2021

SELL
$15.39 - $18.97 $664,617 - $819,219
-43,185 Reduced 21.54%
157,304 $2.86 Million
Q3 2020

Nov 16, 2020

SELL
$17.1 - $19.19 $70,400 - $79,005
-4,117 Reduced 2.01%
200,489 $3.58 Million
Q2 2020

Aug 14, 2020

SELL
$14.59 - $19.5 $205,120 - $274,150
-14,059 Reduced 6.43%
204,606 $3.67 Million
Q1 2020

May 14, 2020

BUY
$13.02 - $20.31 $37,120 - $57,903
2,851 Added 1.32%
218,665 $3.32 Million
Q4 2019

Feb 13, 2020

BUY
$16.88 - $20.83 $432,955 - $534,268
25,649 Added 13.49%
215,814 $4.26 Million
Q3 2019

Nov 19, 2019

BUY
$16.15 - $17.99 $2,390 - $2,662
148 Added 0.08%
190,165 $3.27 Million
Q3 2019

Nov 13, 2019

SELL
$16.15 - $17.99 $291,329 - $324,521
-18,039 Reduced 8.67%
190,017 $3.27 Million
Q2 2019

Aug 14, 2019

BUY
$16.58 - $20.49 $108,400 - $133,963
6,538 Added 3.24%
208,056 $3.68 Million
Q1 2019

May 14, 2019

BUY
$16.7 - $21.52 $3.37 Million - $4.34 Million
201,518 New
201,518 $4.1 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.8B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.